Nausheen Ahmed MD
Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology, Sickle Cell & Other Anemias
Associate Professor
Join to View Full Profile
2330 Shawnee Mission PkwyStop 5003Westwood, KS 66205
Phone+1 913-588-9832
Fax+1 423-408-7405
Dr. Ahmed is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Nausheen Ahmed is a Hematologist based in Westwood, KS with subspecialties in Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology, and Sickle Cell & Other Anemias. She completed her residency in Internal Medicine at the University of Connecticut, followed by fellowships in Hematology and Medical Oncology at UMass Chan and Case Western Reserve University respectively. Since 2019, she has been working as a Clinical Fellow at UH Cleveland Medical Center. Dr. Ahmed’s research, including studies on hematopoietic cell transplantation, CAR T cell therapy, and checkpoint inhibition in aggressive B-cell lymphomas, has been extensively published in professional journals. Among her several articles, one has been cited by four other publications.
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
UMass Chan - BaystateFellowship, Hematology and Medical Oncology, 2012 - 2015
Aga Khan Medical CollegeClass of 2003
University of ConnecticutResidency, Internal Medicine
Certifications & Licensure
KS State Medical License 2020 - 2026
MO State Medical License 2021 - 2026
OH State Medical License 2017 - 2021
TN State Medical License 2015 - 2019
VA State Medical License 2015 - 2018
MA State Medical License 2012 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Global Access to Multiple Myeloma Therapies.Rawan Atallah, Yara Shatnawi, Md Fathima Shehnaz Ayoobkhan, Md Saiful Islam Saif, Menahil Naeem
JCO Global Oncology. 2025-06-01 - Attitudes and perspectives of oncologists about measurable residual disease testing in multiple myeloma: initiative for standardizing guidelines.Aqeeb Ur Rehman, Fathima Shehnaz Ayoobkhan, Moazzam Shahzad, Muhammad Kashif Amin, Sara Shatnawi
Bone Marrow Transplantation. 2025-05-05 - 1 citationsChimeric antigen receptor T cell therapy in octogenarians with B cell lymphoma: a real-world US multicenter collaborative study.Mohamed A Kharfan-Dabaja, Razan Mohty, Neela Easwar, Patrick Johnston, Madiha Iqbal
Bone Marrow Transplantation. 2025-05-01
Press Mentions
Should FDA’s Toxicity Guidance for CAR-T Be Changed?August 13th, 2024- Toxicities Rare After Two Weeks of CAR T-cell Therapy InfusionJuly 31st, 2024
- FDA-Mandated CAR-T Monitoring Period Could Be HalvedJuly 24th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
